首页> 外文期刊>Expert opinion on drug delivery >Delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial disease
【24h】

Delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial disease

机译:通过核心病例,心外膜和肌动脉内容进行药物,生长因子,基因和干细胞的持续局部靶向治疗心肌病

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Local myocardial delivery (LMD) of therapeutic agents is a promising strategy that aims to treat various myocardial pathologies. It is designed to deliver agents directly to the myocardium and minimize their extracardiac concentrations and side effects. LMD aims to enhance outcomes of existing therapies by broadening their therapeutic window and to utilize new agents that could not be otherwise be implemented systemically.
机译:简介:治疗剂的局部心肌递送(LMD)是一种有希望的策略,旨在治疗各种心肌病理学。 它设计用于将药剂直接递送到心肌,并最大限度地减少其肢体浓度和副作用。 LMD旨在通过扩大治疗窗口并利用无法系统地实施的新代理来增强现有疗法的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号